Making Drugs Cheaper Without Stifling Innovation -- Euro Style

The video discusses the concept of reference pricing in pharmaceuticals, highlighting how it can lower drug costs while encouraging innovation. It compares drug pricing strategies in Europe and the U.S., explaining how reference pricing groups drugs into classes and sets a standard price, pressuring manufacturers to lower costs. The video also explores extending this approach to medical technologies and specific cases like cancer drugs, emphasizing cost-effectiveness. The discussion includes potential benefits and criticisms, advocating for smarter innovation in healthcare.

What new insight or understanding did you gain from this video?